(Q36552496)

14 August 2017

1 reference

title

Selective alpha 1-adrenoreceptor blockers in the treatment of hypertension: should we be using them more? (English)

1 reference

14 August 2017

Selective α1-adrenoreceptor blockers in the treatment of hypertension: Should we be using them more? (English)

1 reference

29 October 2022

3

M. Wilkins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1687998

29 October 2022

author name string

M. Ligueros

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1687998

29 October 2022

R. Unwin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1687998

29 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1687998

29 October 2022

publication date

1 September 1991

1 reference

full work available at URL

14 August 2017

http://link.springer.com/content/pdf/10.1007/BF01824996.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01824996/fulltext.html

29 October 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF01824996

29 October 2022

1 reference

Clinical Autonomic Research

29 October 2022

published in

1 reference

14 August 2017

volume

1

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

251-258

1 reference

Plasma catecholamines and essential hypertension. An analytical review

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01824996

Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01824996

Studies of the mechanisms underlying impairment of beta-adrenoceptor-mediated effects in human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01824996

Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01824996

Amelioration of systemic hypertension by converting enzyme inhibition in the renal ablation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01824996

Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01824996

Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01824996

A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01824996

Prazosin in the Treatment of Prostatic Obstruction A Placebo-controlled Study

21 January 2018

1 reference

12 December 2020

Mechanism of renal hypertension

1 reference

12 December 2020

24-hour control of blood pressure by once daily doxazosin: a multicentre double-blind comparison with placebo

1 reference

12 December 2020

Presynaptic regulation of catecholamine release

1 reference

12 December 2020

A comparison of doxazosin and enalapril in the treatment of mild and moderate essential hypertension.

1 reference

12 December 2020

Long-term experience with terazosin for treatment of mild to moderate hypertension.

1 reference

12 December 2020

Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.

1 reference

12 December 2020

Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension

1 reference

12 December 2020

Prazosin versus captopril as initial therapy. Effect on hypertension and lipid levels

1 reference

12 December 2020

Myocardial hypertrophy: the effect of sodium and the role of sympathetic nervous system activity

1 reference

12 December 2020

Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension

1 reference

12 December 2020

Cumulative experience with terazosin administered in combination with diuretics

1 reference

12 December 2020

Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness

1 reference

12 December 2020

Mechanism of elevated plasma noradrenaline in the course of essential hypertension

1 reference

12 December 2020

The emerging field of borderline hypertension

1 reference

12 December 2020

Role of the central nervous system in human secondary hypertension

1 reference

12 December 2020

Left ventricular hypertrophy, arrhythmias and sudden death in systemic hypertension.

1 reference

12 December 2020

Physiological aspects of primary hypertension

1 reference

12 December 2020

alpha 1-antagonists in the treatment of hypertension

1 reference

12 December 2020

A double-blind comparative study of doxazosin and nitrendipine in patients with mild-to-moderate essential hypertension

1 reference

12 December 2020

Comparison of doxazosin and atenolol in mild hypertension, and effects on exercise capacity, hemodynamics and left ventricular function.

1 reference

12 December 2020

Are there multiple imidazoline binding sites?

1 reference

12 December 2020

Pharmacotherapeutic stature of doxazosin and its role in coronary risk reduction

1 reference

12 December 2020

Decreased Beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension

1 reference

12 December 2020

Comparison of the antihypertensive activities of xipamide and chlorthalidone: a double-blind, randomized, crossover trial

1 reference

12 December 2020

Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension

1 reference

12 December 2020

Altered cardiac responsiveness and regulation in the normal cardiac output type of borderlind hlpertension

1 reference

12 December 2020

The safety and efficacy of terazosin for the treatment of benign prostatic hyperplasia

1 reference

12 December 2020

Prazosin-induced priapism. Pathogenic and therapeutic implications

1 reference

12 December 2020

Clinical experience with doxazosin in general medical practice.

1 reference

12 December 2020

Chronic effects of direct vasodilation (pinacidil), alpha-adrenergic blockade (prazosin) and angiotensin-converting enzyme inhibition (captopril) in systemic hypertension.

1 reference

12 December 2020

Autonomic nervous cardiovascular regulation in borderline hypertension

1 reference

12 December 2020

Direct evaluation of acidification by rat proximal tubule: role of carbonic anhydrase

1 reference

12 December 2020

Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension

1 reference

12 December 2020

Drug therapy. Prazosin

1 reference

12 December 2020

Effects of prazosin and propranolol on serum lipids in patients with essential hypertension

1 reference

12 December 2020

Hemodynamic Studies in Patients with Borderline Blood Pressure Elevation

1 reference

12 December 2020

Hemodynamic study of 85 patients with borderline hypertension

1 reference

12 December 2020

Behavioral Stress and Cardiac Arrhythmias

1 reference

12 December 2020

Sympathetic nervous system and blood-pressure control in essential hypertension

1 reference

12 December 2020

This and that: an unsuitable eponym, leeches, and the transmutation of the disciplines

1 reference

12 December 2020

[The effect of the beta-blocker nadolol on the second messenger, serum cyclic adenosine monophosphate, and on blood pressure and heart rate]

1 reference

12 December 2020

Pharmacokinetic overview of doxazosin

1 reference

12 December 2020

Effects of doxazosin on vascular collagen synthesis, arterial pressure and serum lipids in the spontaneously hypertensive rat

1 reference

12 December 2020

1 reference

12 December 2020

Cardiovascular ?-receptors

1 reference

12 December 2020

Effects of angiotensin on the central nervous system

1 reference

12 December 2020

The antihypertensive effects of doxazosin: a clinical overview

1 reference

12 December 2020

Role of alpha adrenoceptors in hypertension and in antihypertensive drug treatment.

1 reference

12 December 2020

Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability.

1 reference

12 December 2020

Role of Parasympathetic Inhibition in the Hyperkinetic Type of Borderline Hypertension

1 reference

12 December 2020

Changing role of the autonomic nervous system in human hypertension

1 reference

12 December 2020

Enalapril Worldwide Experience

1 reference

12 December 2020

Overall safety of terazosin as an antihypertensive agent

1 reference

12 December 2020

Sympathoadrenal activity, catecholamines, and the pathogenesis of vasculopathic hypertensive target-organ damage

1 reference

12 December 2020

Presence of Postsynaptic α2-Adrenoreceptors of Predominantly Extrasynaptic Location in the Vascular Smooth Muscle of the Dog Hind Limb

1 reference

12 December 2020

Antihypertensive effects of doxazosin in systemic hypertension and comparison with terazosin

1 reference

12 December 2020

Clonidine Lowers Blood Pressure Independently of Renin Suppression In Patients with Unilateral Renal Artery Stenosis

1 reference

12 December 2020

Vasodilators and regression of left ventricular hypertrophy. Hydralazine versus prazosin in hypertensive humans

1 reference

12 December 2020

Vascular hypertrophy in borderline hypertension: relationship to blood pressure and sympathetic drive

1 reference

12 December 2020

Traditional first-line therapy. Overview of medical benefits and side effects

1 reference

12 December 2020

Effects of two antihypertensive agents on lipids, lipoproteins, and apoproteins A and B. Comparison of prazosin and atenolol

1 reference

12 December 2020

Initial antihypertensive drug therapy: alpha blocker or diuretic. Interim report of a randomized, controlled trial

1 reference

12 December 2020

Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg

1 reference

12 December 2020

Bladder-neck opening test in spinal cord injury patients using a new i.v. alpha-blocking agent, alfuzosin

1 reference

12 December 2020

Terazosin: an effective once-daily monotherapy for the treatment of hypertension

1 reference

12 December 2020

Terazosin (Hytrin): cumulative experience of clinical trials in the USA for the treatment of mild to moderate essential hypertension

1 reference

12 December 2020

Effects of prazosin and phentolamine on arterial pressure, heart rate, and renin activity: evidence in the conscious rat for the functional significance of the presynaptic alpha-receptor

1 reference

12 December 2020

Experience with terazosin administered in combination with other antihypertensive agents

1 reference

12 December 2020

The characteristics of alpha-adrenoceptors mediating the renal nerve induced antinatriuresis and antidiuresis in hypertensive rats

1 reference

12 December 2020

The usefulness of alpha-adrenoceptor blockade in the treatment of hypertension

1 reference

12 December 2020

A twelve-week placebo-controlled study of prazosin in the treatment of prostatic obstruction

1 reference

12 December 2020

Plasma cyclic GMP: Response to cholinergic agents

1 reference

12 December 2020

Appraisal and reappraisal of cardiac therapy: prazosin

1 reference

12 December 2020

Acta medica Scandinavica

5

482

1

P Lunds-Johansen

1967

1 reference

American Journal of Physiology

29 October 2022

31

238

F372

MS Lucci

1980

1 reference

29 October 2022

Pharmacological Reviews

33

25

415

WB Severs

1973

1 reference

The British journal of clinical practice

29 October 2022

61

41

9

JL Pool

1987

1 reference

Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study

29 October 2022

series ordinal

62

1 reference

International journal of clinical pharmacology, therapy, and toxicology

29 October 2022

88

27

392

H Lepor

1989

1 reference

29 October 2022

Identifiers

DOI

10.1007/BF01824996

1 reference

14 August 2017

1 reference